Telangana: Drugs Control Administration, Telangana, has seized Spurious Drugs (Counterfeit Versions) 'Montek-LC' Tablets ...

The share price of Sun Pharmaceuticals Industries (Sun Pharma) is shining bright, the top gainer in intra-day trade, up 3%. This surge in the share price came after the company announced an ...

The stock of the country’s largest pharmaceutical company, Sun Pharmaceutical Industries (Sun Pharma), has shed about 15 per cent from its highs over the last three months. Weak US sales trajectory, ...

Sun Pharmaceutical Industries has agreed to acquire US-based cancer drug maker in a deal valued at $355 million in upfront cash payment, India’s biggest pharma company said in a press release ...

Sun Pharma, India's largest pharmaceutical company, is set to acquire Checkpoint Therapeutics for $355 million. This strategic acquisition will enhance Sun Pharma's specialty portfolio ...

Sun Pharma (Sun) is acquiring US-based early-stage oncology-focused biotech company Checkpoint Therapeutics (Checkpoint) for an upfront cash payment of USD 4.1/share (total outgo of USD 355mn ...

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 11, 2025 for Raksha Valia ...

Sun Pharmaceutical Industries Ltd. 524715 shares rallied 2.76% to 1,655.65 Indian rupees Tuesday, on what proved to be an all-around rough trading session for the stock market, with the BSE SENSEX ...

Sun Pharma share price today reached ₹1,651.80, a 2.50% rise from its last close of ₹1,611.50. The rise is despite the overall market downtrend, highlighting Sun Pharma's strength in the pharma ...

March 10, 2025 India's Sun Pharma to acquire Checkpoint Therapeutics for $355 million India's Sun Pharmaceutical Industries said on Monday it will acquire Checkpoint Therapeutics , a U.S.-based ...

Sun Pharmaceutical Industries has agreed to acquire Checkpoint Therapeutics, Inc. for $4.10 per share, a 65% premium to last traded price, post-FDA approval of Unloxcyt for metastatic cutaneous ...

Sun Pharmaceutical Industries Ltd. has announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, Inc., an immunotherapy and targeted oncology company, in a $355 million cash deal.